Losartan Dosage and Treatment Guidelines for Hypertension
The recommended starting dose of losartan for hypertension is 50 mg once daily, with titration to a maximum of 100 mg once daily as needed to control blood pressure. 1
Initial Dosing and Titration
- Starting dose: 50 mg once daily for most adults with hypertension 1
- Lower starting dose (25 mg) recommended for:
- Maximum dose: 100 mg once daily 1
- Titration should be based on blood pressure response, with dosage adjustments typically made after 2-4 weeks
Special Populations
- Renal impairment: No initial dosage adjustment necessary for various degrees of renal insufficiency 2
- Hepatic impairment:
- Elderly: No specific dosage adjustment required based on age alone 2
- Pediatric patients:
Specific Indications and Dosing
- Hypertension with left ventricular hypertrophy:
- Diabetic nephropathy:
Monitoring and Follow-up
- Monitor blood pressure regularly to assess response
- Check serum potassium and renal function:
- At baseline
- Within 1-2 weeks of initiation or dose changes
- Periodically during treatment
- Target blood pressure should generally be <140/90 mmHg if tolerated 4
- Re-evaluate patients with stage 1 hypertension within 1 month and those with stage 2 hypertension within 1 month of diagnosis 4
Combination Therapy
- If blood pressure remains uncontrolled on maximum losartan dose:
Precautions and Contraindications
- Avoid use in pregnancy (especially second and third trimesters) due to risk of fetal toxicity 2
- Use caution in patients with bilateral renal artery stenosis 4
- Monitor for hyperkalemia, especially in patients with:
- Chronic kidney disease
- Concomitant use of potassium-sparing diuretics
- Potassium supplements
Effectiveness and Tolerability
- Losartan effectively reduces blood pressure with once-daily dosing 6
- Generally well-tolerated with fewer side effects than ACE inhibitors (less cough) 2
- In patients with hypertension and LVH, losartan has been shown to reduce stroke risk compared to atenolol 7, 8
Losartan can be administered without regard to meals and has a favorable drug interaction profile, with no clinically significant interactions with hydrochlorothiazide, warfarin, or digoxin 2.